Skip to main content
. 2021 Oct 21;139(12):1–8. doi: 10.1001/jamaophthalmol.2021.4103

Figure 2. Time to Lapse in Care and Dropping Out Among Participants Assigned to Ranibizumab.

Figure 2.

Time to first lapse in care was the target date for the next scheduled visit that triggered the lapse in care. Time to dropping out was the last completed visit date. Participants who completed the study without a lapse in care were censored at 260 weeks.